Ramzi Abboud

13PUBLICATIONS
51CO-AUTHORS
Transplantation immunologyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 31, 2026
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

|Aug 19, 2026
Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial.

|Oct 06, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide.

Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor

|Nov 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation.

Ramzi Abboud, Mark A Schroeder, Michael P Rettig

|Jul 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.

Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor

|Jul 11, 2024
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant.

Hunter Cassidy Cochran, Michael Joseph Slade, Chang Liu

Pageof 3

Frequent Collaborators

4 joint publications

Monzr M Al Malki

3 joint publications

Dipenkumar Modi

3 joint publications

Steven M Devine

3 joint publications

Antonio Martin Jimenez Jimenez